Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Other Non-Current Liabilities: 2020

  • Cogent Biosciences' Other Non-Current Liabilities was N/A to $5.5 million in Q4 2020 from the same period last year, while for Dec 2020 it was $5.5 million, marking a year-over-year change of. This contributed to the annual value of $5.5 million for FY2020, which is N/A change from last year.
  • Latest data reveals that Cogent Biosciences reported Other Non-Current Liabilities of $5.5 million as of Q4 2020.
  • Over the past 5 years, Cogent Biosciences' Other Non-Current Liabilities peaked at $5.5 million during Q4 2020, and registered a low of $5.5 million during Q4 2020.
  • Moreover, its 1-year median value for Other Non-Current Liabilities was $5.5 million (2020), whereas its average is $5.5 million.